Comments
Loading...

Moderna Analyst Ratings

MRNANASDAQ
Logo brought to you by Benzinga Data
Consensus Rating1
Hold
Highest Price Target1
$208.00
Lowest Price Target1
$33.00
Consensus Price Target1
$75.22

Moderna Analyst Ratings and Price Targets | NASDAQ:MRNA | Benzinga

Moderna Inc has a consensus price target of $75.22 based on the ratings of 28 analysts. The high is $208 issued by Chardan Capital on January 18, 2023. The low is $33 issued by JP Morgan on March 21, 2025. The 3 most-recent analyst ratings were released by JP Morgan, Citigroup, and UBS on March 21, 2025, March 13, 2025, and February 19, 2025, respectively. With an average price target of $50.33 between JP Morgan, Citigroup, and UBS, there's an implied 46.74% upside for Moderna Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
2
2
Jan
1
1
1
Feb
1
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
1.9
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JP Morgan
Citigroup
UBS
RBC Capital
Barclays

1calculated from analyst ratings

Analyst Ratings for Moderna

Buy NowGet Alert
03/21/2025Buy Now-3.79%JP Morgan
Jessica Fye68%
$40 → $33MaintainsUnderweightGet Alert
03/13/2025Buy Now16.62%Citigroup
Geoff Meacham63%
→ $40Initiates → NeutralGet Alert
02/19/2025Buy Now127.41%UBS
Eliana Merle46%
$96 → $78MaintainsBuyGet Alert
02/18/2025Buy Now16.62%RBC Capital
Luca Issi40%
$40 → $40ReiteratesSector Perform → Sector PerformGet Alert
02/18/2025Buy Now31.2%Barclays
Gena Wang50%
$111 → $45DowngradeOverweight → Equal-WeightGet Alert
02/11/2025Buy Now-0.87%B of A Securities
Tim Anderson53%
$41 → $34MaintainsUnderperformGet Alert
01/29/2025Buy Now48.69%Goldman Sachs
Salveen Richter52%
$99 → $51DowngradeBuy → NeutralGet Alert
01/28/2025Buy Now188.63%Goldman Sachs
Salveen Richter52%
$112 → $99MaintainsBuyGet Alert
01/27/2025Buy Now45.77%Evercore ISI Group
Cory Kasimov69%
$60 → $50MaintainsIn-LineGet Alert
01/15/2025Buy Now10.79%Morgan Stanley
Matthew Harrison60%
$70 → $38MaintainsEqual-WeightGet Alert
01/08/2025Buy Now179.88%UBS
Eliana Merle46%
$108 → $96MaintainsBuyGet Alert
12/18/2024Buy NowArgus Research
John Eade74%
DowngradeBuy → HoldGet Alert
12/10/2024Buy Now19.53%B of A Securities
Tim Anderson53%
→ $41Reinstates → UnderperformGet Alert
11/26/2024Buy Now31.2%JP Morgan
Jessica Fye68%
$59 → $45MaintainsUnderweightGet Alert
11/18/2024Buy Now101.17%Piper Sandler
Edward Tenthoff52%
$115 → $69ReiteratesOverweight → OverweightGet Alert
11/18/2024Buy Now69.1%HSBC
Yifeng Liu39%
→ $58UpgradeHold → BuyGet Alert
11/15/2024Buy Now16.62%Wolfe Research
Alexandria Hammond43%
→ $40Initiates → UnderperformGet Alert
11/08/2024Buy Now223.62%Barclays
Gena Wang50%
$125 → $111MaintainsOverweightGet Alert
11/08/2024Buy NowNeedham
Joseph Stringer50%
Reiterates → HoldGet Alert
11/04/2024Buy Now72.01%JP Morgan
Jessica Fye68%
$70 → $59MaintainsUnderweightGet Alert
10/24/2024Buy Now214.87%UBS
Eliana Merle46%
$140 → $108MaintainsBuyGet Alert
10/17/2024Buy Now60.35%Bernstein
Courtney Breen1%
→ $55Initiates → Market PerformGet Alert
10/15/2024Buy Now60.35%Jefferies
Michael Yee56%
$65 → $55MaintainsHoldGet Alert
09/19/2024Buy Now118.66%RBC Capital
Luca Issi40%
$75 → $75ReiteratesSector Perform → Sector PerformGet Alert
09/16/2024Buy Now305.25%Goldman Sachs
Salveen Richter52%
$178 → $139MaintainsBuyGet Alert
09/16/2024Buy Now264.43%Barclays
Gena Wang50%
$155 → $125MaintainsOverweightGet Alert
09/13/2024Buy Now220.7%B of A Securities
Geoff Meacham63%
$130 → $110MaintainsNeutralGet Alert
09/13/2024Buy Now235.28%Piper Sandler
Edward Tenthoff52%
$157 → $115MaintainsOverweightGet Alert
09/13/2024Buy Now74.93%TD Cowen
Tyler Van Buren48%
$70 → $60MaintainsHoldGet Alert
09/13/2024Buy Now118.66%RBC Capital
Luca Issi40%
$90 → $75MaintainsSector PerformGet Alert
09/13/2024Buy Now104.08%JP Morgan
Jessica Fye68%
$88 → $70DowngradeNeutral → UnderweightGet Alert
09/13/2024Buy Now89.5%Jefferies
Michael Yee56%
$120 → $65DowngradeBuy → HoldGet Alert
09/13/2024Buy NowOppenheimer
Hartaj Singh47%
DowngradeOutperform → PerformGet Alert
09/13/2024Buy NowNeedham
Joseph Stringer50%
Reiterates → HoldGet Alert
08/28/2024Buy Now139.07%HSBC
Yifeng Liu39%
→ $82UpgradeReduce → HoldGet Alert
08/15/2024Buy Now156.56%JP Morgan
Jessica Fye68%
$96 → $88MaintainsNeutralGet Alert
08/06/2024Buy Now133.24%Deutsche Bank
Emmanuel Papadakis48%
$85 → $80UpgradeSell → HoldGet Alert
08/05/2024Buy Now162.39%RBC Capital
Luca Issi40%
$125 → $90DowngradeOutperform → Sector PerformGet Alert
08/02/2024Buy Now264.43%RBC Capital
Luca Issi40%
$160 → $125MaintainsOutperformGet Alert
08/02/2024Buy Now418.95%Goldman Sachs
Salveen Richter52%
$204 → $178MaintainsBuyGet Alert
08/02/2024Buy Now351.9%Barclays
Gena Wang50%
$168 → $155MaintainsOverweightGet Alert
08/02/2024Buy Now357.73%Piper Sandler
Edward Tenthoff52%
$214 → $157ReiteratesOverweight → OverweightGet Alert
08/01/2024Buy NowNeedham
Joseph Stringer50%
Reiterates → HoldGet Alert
06/28/2024Buy NowNeedham
Joseph Stringer50%
Reiterates → HoldGet Alert
06/27/2024Buy Now523.91%Piper Sandler
Edward Tenthoff52%
$214 → $214ReiteratesOverweight → OverweightGet Alert
06/27/2024Buy Now249.85%Evercore ISI Group
Cory Kasimov69%
$120 → $120MaintainsIn-LineGet Alert
06/12/2024Buy Now179.88%JP Morgan
Jessica Fye68%
$85 → $96MaintainsNeutralGet Alert
06/12/2024Buy Now421.87%Oppenheimer
Hartaj Singh47%
$163 → $179MaintainsOutperformGet Alert
06/03/2024Buy Now366.47%RBC Capital
Luca Issi40%
$135 → $160MaintainsOutperformGet Alert
06/03/2024Buy NowNeedham
Joseph Stringer50%
Reiterates → HoldGet Alert
05/14/2024Buy Now249.85%Evercore ISI Group
Cory Kasimov69%
→ $120Initiates → In-LineGet Alert
05/07/2024Buy Now340.23%UBS
Eliana Merle46%
$143 → $151MaintainsBuyGet Alert
05/03/2024Buy Now209.04%Canaccord Genuity
Bill Maughan19%
$91 → $106MaintainsHoldGet Alert
05/03/2024Buy Now293.59%RBC Capital
Luca Issi40%
$125 → $135MaintainsOutperformGet Alert
05/03/2024Buy Now375.22%Oppenheimer
Hartaj Singh47%
$142 → $163MaintainsOutperformGet Alert
05/02/2024Buy NowNeedham
Joseph Stringer50%
Reiterates → HoldGet Alert
04/11/2024Buy NowNeedham
Joseph Stringer50%
Reiterates → HoldGet Alert
04/09/2024Buy Now264.43%Jefferies
Michael Yee56%
→ $125ReiteratesBuy → BuyGet Alert
03/28/2024Buy Now264.43%RBC Capital
Luca Issi40%
$125 → $125ReiteratesOutperform → OutperformGet Alert
03/28/2024Buy NowNeedham
Joseph Stringer50%
Reiterates → HoldGet Alert
03/15/2024Buy Now147.81%JP Morgan
Jessica Fye68%
$90 → $85MaintainsNeutralGet Alert
02/26/2024Buy Now150.73%HSBC
Yifeng Liu39%
$75 → $86DowngradeHold → ReduceGet Alert
02/23/2024Buy Now264.43%RBC Capital
Luca Issi40%
$125 → $125ReiteratesOutperform → OutperformGet Alert
02/23/2024Buy Now165.31%Canaccord Genuity
Bill Maughan19%
$82 → $91MaintainsHoldGet Alert
01/12/2024Buy Now264.43%RBC Capital
Luca Issi40%
$125 → $125ReiteratesOutperform → OutperformGet Alert
01/02/2024Buy Now313.99%Oppenheimer
Hartaj Singh47%
→ $142UpgradePerform → OutperformGet Alert
12/01/2023Buy Now162.39%JP Morgan
Jessica Fye68%
$93 → $90MaintainsNeutralGet Alert
11/29/2023Buy Now139.07%Canaccord Genuity
Bill Maughan19%
→ $82Initiates → HoldGet Alert
11/03/2023Buy Now264.43%RBC Capital
Luca Issi40%
$180 → $125MaintainsOutperformGet Alert
11/03/2023Buy Now573.47%Goldman Sachs
Salveen Richter52%
$269 → $231MaintainsBuyGet Alert
11/03/2023Buy Now101.17%HSBC
Yifeng Liu39%
$89 → $69UpgradeReduce → HoldGet Alert
11/02/2023Buy NowDeutsche Bank
Emmanuel Papadakis48%
DowngradeHold → SellGet Alert
09/13/2023Buy Now308.16%Argus Research
Jasper Hellweg70%
$160 → $140MaintainsBuyGet Alert
08/04/2023Buy Now258.6%Morgan Stanley
Matthew Harrison60%
$128 → $123MaintainsEqual-WeightGet Alert
08/04/2023Buy Now337.32%B of A Securities
Geoff Meacham63%
$175 → $150MaintainsNeutralGet Alert
08/04/2023Buy Now453.94%RBC Capital
Luca Issi40%
$200 → $190MaintainsOutperformGet Alert
08/04/2023Buy Now264.43%TD Cowen
Tyler Van Buren48%
$145 → $125DowngradeOutperform → Market PerformGet Alert
08/03/2023Buy Now264.43%Deutsche Bank
Emmanuel Papadakis48%
$200 → $125DowngradeBuy → HoldGet Alert
07/24/2023Buy Now381.05%TD Cowen
Tyler Van Buren48%
$175 → $165MaintainsOutperformGet Alert
07/24/2023Buy NowWilliam Blair
Myles Minter44%
Initiates → Market PerformGet Alert
07/14/2023Buy Now182.8%HSBC
Rajesh Kumar65%
→ $97Initiates → ReduceGet Alert
07/11/2023Buy Now273.18%Morgan Stanley
Matthew Harrison60%
$153 → $128MaintainsEqual-WeightGet Alert
06/26/2023Buy Now456.85%UBS
Eliana Merle46%
$221 → $191UpgradeNeutral → BuyGet Alert
05/05/2023Buy Now462.68%Morgan Stanley
Matthew Harrison60%
$185 → $193MaintainsEqual-WeightGet Alert
04/26/2023Buy NowGuggenheim
Evan Wang8%
Initiates → NeutralGet Alert
04/12/2023Buy Now308.16%JP Morgan
Jessica Fye68%
$145 → $140MaintainsNeutralGet Alert
04/10/2023Buy Now322.74%JP Morgan
Jessica Fye68%
$127 → $145MaintainsNeutralGet Alert
03/13/2023Buy Now424.78%TD Cowen
Tyler Van Buren48%
$150 → $180UpgradeMarket Perform → OutperformGet Alert
03/02/2023Buy Now483.09%RBC Capital
Luca Issi40%
→ $200Initiates → OutperformGet Alert
02/28/2023Buy Now483.09%Deutsche Bank
Emmanuel Papadakis48%
$225 → $200MaintainsBuyGet Alert
02/24/2023Buy Now171.14%SVB Leerink
Mani Foroohar46%
$111 → $93DowngradeMarket Perform → UnderperformGet Alert
02/08/2023Buy Now302.33%JP Morgan
Jessica Fye68%
$132 → $138MaintainsNeutralGet Alert
01/25/2023Buy Now337.32%Cowen & Co.
Tyler Van Buren48%
$130 → $150MaintainsMarket PerformGet Alert
01/24/2023Buy Now497.67%Morgan Stanley
Matthew Harrison60%
$209 → $205MaintainsEqual-WeightGet Alert
01/18/2023Buy Now223.62%SVB Leerink
Mani Foroohar46%
$102 → $111MaintainsMarket PerformGet Alert
01/18/2023Buy Now506.41%Chardan Capital
Geulah Livshits46%
$191 → $208MaintainsNeutralGet Alert
12/20/2022Buy Now532.65%Piper Sandler
Edward Tenthoff52%
$214 → $217MaintainsOverweightGet Alert
12/19/2022Buy Now701.75%Jefferies
Michael Yee56%
$170 → $275UpgradeHold → BuyGet Alert
12/16/2022Buy Now509.33%Morgan Stanley
Matthew Harrison60%
$170 → $209MaintainsEqual-WeightGet Alert
12/14/2022Buy Now456.85%Chardan Capital
Geulah Livshits46%
$186 → $191DowngradeBuy → NeutralGet Alert

FAQ

Q

What is the target price for Moderna (MRNA) stock?

A

The latest price target for Moderna (NASDAQ:MRNA) was reported by JP Morgan on March 21, 2025. The analyst firm set a price target for $33.00 expecting MRNA to fall to within 12 months (a possible -3.79% downside). 60 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Moderna (MRNA)?

A

The latest analyst rating for Moderna (NASDAQ:MRNA) was provided by JP Morgan, and Moderna maintained their underweight rating.

Q

When was the last upgrade for Moderna (MRNA)?

A

The last upgrade for Moderna Inc happened on November 18, 2024 when HSBC raised their price target to $58. HSBC previously had a hold for Moderna Inc.

Q

When was the last downgrade for Moderna (MRNA)?

A

The last downgrade for Moderna Inc happened on February 18, 2025 when Barclays changed their price target from $111 to $45 for Moderna Inc.

Q

When is the next analyst rating going to be posted or updated for Moderna (MRNA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moderna, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moderna was filed on March 21, 2025 so you should expect the next rating to be made available sometime around March 21, 2026.

Q

Is the Analyst Rating Moderna (MRNA) correct?

A

While ratings are subjective and will change, the latest Moderna (MRNA) rating was a maintained with a price target of $40.00 to $33.00. The current price Moderna (MRNA) is trading at is $34.30, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch